National Pathology Congress 2026: A Gathering of Experts in Precision Medicine
On April 24 and 25, 2026, Rabat, the capital city of Morocco, will host the National Pathology Congress 2026, a significant scientific event that will bring together renowned experts in pathology, oncology, and medical biology from Morocco and around the globe. This prestigious congress will take place at the Four Seasons Hotel Rabat at Kasr Al Bahr, providing a platform for the exchange of innovative ideas and advancements in the field of pathology.
The congress is designed to offer a comprehensive scientific program focused on diagnostic innovations, biomarkers, and novel therapeutic approaches for the most common types of cancer. Additionally, it will address critical issues relating to quality and accreditation standards for pathology laboratories. The opening symposium will spotlight HER2-low breast cancer, emphasizing the evolving role of pathologists in therapeutic decision-making within the realm of personalized medicine.
Exploring Frontiers in Cancer Research and Diagnosis
Discussions will center on the quality of sample handling, updates on HER2 testing techniques, and the increasing influence of artificial intelligence in anatomical pathology analysis. Following this, the second session will delve into recent advancements in colorectal cancer, highlighting the World Health Organization's new classifications, emerging biomarkers, and the potential of methylation analysis in understanding tumor biology and guiding therapy.
The Saturday agenda will feature a session dedicated to lung cancers, where international experts will present on the current limitations of tumor sequencing, the growing role of liquid biopsies, and updated molecular classifications along with diagnostic algorithms tailored for lung carcinomas. Moreover, a key focus will be placed on the organization and accreditation of biopathology laboratories, with discussions surrounding ISO 15189 standards, digital pathology, standardized reporting, and the validation of molecular tests in oncology—all aimed at enhancing the quality and reliability of diagnostics in Morocco.
The congress will also include a critical session on non-tumoral liver pathology, where experts will discuss the applications of artificial intelligence in analyzing liver lesions, clinicians' expectations from pathologists regarding liver vascular diseases, and the diagnostic challenges related to liver transplant rejection. Notably, the event will conclude with a session dedicated to young pathologists, providing a platform for the new generation of specialists to share experiences and insights.
Overall, the National Pathology Congress 2026 aims to serve as a vital scientific forum to foster collaboration among pathologists, oncologists, biologists, and clinicians. It aspires to reinforce the strategic role of pathology in precision medicine and improve cancer care in Morocco and the surrounding region. With its rich array of topics and distinguished speakers, this congress is poised to make significant contributions to the advancement of biopathology and patient care.
As reported by lopinion.ma.
